ECONOMIC DAILY NEWS: REPORTER TIAN YUAN REPORTED THAT THE LATEST REPORT FROM THE ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT SHOWS THAT IN THE NEXT 15 YEARS, THE GROWTH RATE OF MEDICAL EXPENDITURE IN MOST OECD MEMBER COUNTRIES WILL EXCEED THE GROWTH RATE OF GROSS DOMESTIC PRODUCT.ACCORDING TO OECD DATA, THE PROPORTION OF HEALTHCARE EXPENDITURE IN THE GROSS DOMESTIC PRODUCT OF OECD MEMBER COUNTRIES IS EXPECTED TO SOAR FROM 8.8% IN 2018 TO 10.2% IN 2030, WITH A PER CAPITA HEALTHCARE EXPENDITURE GROWTH RATE OF 2.7%. IN 2018, HEALTHCARE EXPENDITURES IN THE UNITED STATES AND SWITZERLAND WERE SIGNIFICANTLY HIGHER AS A PERCENTAGE OF GDP, AT 16.9% AND 12.2%, RESPECTIVELY; GERMANY, FRANCE, SWEDEN, AND JAPAN ARE ALSO ABOVE THE OECD AVERAGE, APPROACHING 11%; LUXEMBOURG, MEXICO, TÜRKIYE, ETC. ARE LOWER THAN THE OECD AVERAGE, IN THE RANGE OF 4% TO 6%.THE REPORT POINTED OUT THAT DUE TO THE HIGH INCIDENCE OF CARDIOVASCULAR DISEASES CAUSED BY OBESITY AND DIABETES, THE AVERAGE LIFE EXPECTANCY OF 19 MEMBER COUNTRIES HAS DECLINED, THE MORTALITY RATE CAUSED BY DRUG USE HAS INCREASED BY 20% SINCE 2011, AND THE MORTALITY RATE OF DISEASES CAUSED BY POOR AIR QUALITY HAS RISEN TO 0.4%.THE REPORT PROPOSES THE FOLLOWING RECOMMENDATIONS FOR OECD MEMBER COUNTRIES TO IMPROVE THE EFFICIENCY OF HEALTHCARE EXPENDITURE. FIRSTLY, INCREASING THE PROPORTION OF BIOPHARMACEUTICAL EXPENDITURE CAN HELP REDUCE THE TOTAL COST OF MEDICATION. GERMANY, CHILE, NEW ZEALAND, AND THE UNITED KINGDOM HAVE ALREADY EXCEEDED 75% IN THIS INDICATOR, BUT SWITZERLAND STILL HAS LESS THAN 25%; SECONDLY, THE HEALTHCARE SYSTEM SHOULD PROVIDE MORE JOB OPPORTUNITIES TO ALLEVIATE THE PRESSURE OF MEDICAL SERVICE PRICES. CURRENTLY, ABOUT 10% OF JOB POSITIONS IN MEMBER COUNTRIES ARE RELATED TO THE HEALTHCARE INDUSTRY; THIRDLY, INCREASE INVESTMENT IN PATIENT SAFETY, ESPECIALLY FOCUSING ON PREVENTING INFECTIONS DURING TREATMENT.